Trainee (Change management linked to the use of clinical study data in medicine evaluation)
Selection procedure reference: EMA/TR/10932
Deadline for applications: 6 May 2025 23:59 CET
The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.
This traineeship opportunity is now open for applications until 6 May 2025 23:59 CET, with an intake on 1 October 2025.
About the traineeship programme
The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master's students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.
Placement description
We are looking for a trainee in the Data Analytics and Methods Task Force.
Specific objectives and projects
During the traineeship, the trainee will work on projects to support the transformation of the European Medicines Regulatory Network (EMRN) to a more data-driven regulatory network. The trainee will be involved in the development and implementation of change management activities (eg., trainings, communication, review of guidance and requirements...) on the use of clinical study data (individual patient data in electronic strucutured format) to support medicine evaluation.
This will include strengthening of the support to EMRN in terms of implementing the use of clinical study data in the regulatory assessment and regularly liaising with a wide range of stakeholders including different EMA functions, national competent authorities, members of the Agency's scientific Committees and Working Parties members, but also international regulatory agencies.
Learning outcomes
The learning outcomes will be
1. Understanding of how the access and use of clinical study data can support medicine evaluation
2. Development and application of effective change management strategies in a complex regulatory environment
3. Understanding the operations of the European Medicines Regulatory Network and its stakeholders, including other international regulatory agencies (e.g. US FDA, Japan PMDA)
4. Working in an interdisciplinary project team, contributing to its objectives through individual tasks and collaboration
5. Working in a stimulating and international environment
Eligibility criteria
To be eligible for consideration for this placement, you are required to:
- enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;
- possess a university degree in business, change management, communication and policy linked to innovations (minimum of three years or more) that must have been obtained between 6 May 2024 and 6 May 2025 or be a university student on an Erasmus + or a similar programme or a PhD student or a Master's student with a previous fully finished degree in the areas mentioned before.
- a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the Common European Framework for Languages
For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.
Additional skills
- A university degree in biostatistics/epidemiology, data science or medicine/pharmacy could also match if the candidate has also good communication skills.
- Experience in international environments and networks, communication
- Knowledge of Agile methodology
Behavioural Competencies
You will demonstrate the following behavioural competencies:
- Communication skills
- Interpersonal skills
- Working with others
- Adaptability
- Research and analytical skills
Expected selection timelines
Deadline for applications | 6 May 2025 23:59 CET |
---|---|
Assessments (remote) | From end of June 2025 to mid-July 2025 |
Decision and offers | By end of July 2025 |
Placement start | 1 October 2025 |
Conditions of traineeship
The traineeship is offered for 10 months (1 October 2025 – 31 July 2026) and takes place at the Agency’s premises in Amsterdam with possibility for teleworking up to 40% of working time from The Netherlands and occasional teleworking from outside The Netherlands. Traineeships are offered for either full-time or part-time (80% or 50%) if combined with university studies.
The Agency pays a monthly stipend of €1,942.19 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining the Agency.
Each trainee will have a mentor at the Agency who will guide the trainee through the programme.
The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA available here.
______________________________________________________________________________________________________
Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The Netherlands
Telephone +31 (0)88 781 6000 - Email recruitment@ema.europa.eu
© European Medicines Agency, 2024. Reproduction is authorised provided the source is acknowledged.
Job Segment:
Change Management, Clinical Research, Medical Research, Data Management, Clinic, Management, Healthcare, Data